Alnylam Pharmaceuticals reported $210.34M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 104.4M 26.29M
Agios Pharmaceuticals AGIO:US USD 32.77M 3.65M
Alnylam Pharmaceuticals ALNY:US USD 210.34M 25.52M
Amgen AMGN:US USD 1.47B 181M
Arrowhead Research ARWR:US USD 22.65M 8.97M
Avrobio Inc AVRO:US USD 7.12M 54K
Biocryst Pharmaceuticals BCRX:US USD 50.15M 13.23M
Biomarin Pharmaceutical BMRN:US USD 245.74M 28.92M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Intercept Pharmaceuticals ICPT:US USD 55.29M 12.02M
Mirati Therapeutics MRTX:US USD 70.82M 10.02M
Moderna Inc MRNA:US USD 375M 97M
Neurocrine Biosciences NBIX:US USD 182.9M 3.4M
Novartis NVS:US USD 3.7B 295M
Ptc Therapeutics PTCT:US USD 92.72M 12.6M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Regulus Therapeutics RGLS:US USD 4.44M 2.18M
Sangamo Biosciences SGMO:US USD 16.44M 205K
Sarepta Therapeutics SRPT:US USD 120.48M 15.69M
Takeda 4502:JP JPY 262.3B 13.57B
Ultragenyx Pharmaceutical RARE:US USD 72.85M 3.01M
Vertex Pharmaceuticals VRTX:US USD 267.4M 20.6M
Xencor XNCR:US USD 12.75M 377K
YTE INCY:US USD 272.82M 6.36M